Wolfe Research think this pharma stock can bounce back and deliver long-term earnings growth

Singapore News News

Wolfe Research think this pharma stock can bounce back and deliver long-term earnings growth
Singapore Latest News,Singapore Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 72%

Analyst Justin Lake upgraded the stock to outperform from 'peer perform,' noting ithas an 'attractive' risk-reward ratio.

Now is not the time for investors to ditch CVS Health , according to Wolf Research. The firm upgraded the stock to outperform from "peer perform," noting it has an "attractive" risk-reward ratio. Analyst Justin Lake raised his price target to $80, implying 16.4% upside from Monday's close of $68.75, which was the firm's previous price target.

" Shares of the pharmaceutical chain have pulled back more than 26% from the start of the year, plunging in mid-August after Blue Shield of California had said it will drop the company's pharmacy benefit management services. The stock has gained 5.5% so far this month, however, and rose 4.4% during Monday's trading session. Shares were up 0.8% premarket Tuesday.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

- Institute for Experimental Medical Research, Oslo, Norway job with Institute for Experimental Medical ResearchPermanent, full-time position as Researcher to establish stem cell technology at Institute for Experimental Medical Research, Oslo, Norway.
Read more »

Kenvue’s Stock Decline Is a ‘Solid’ Buying OpportunityKenvue’s Stock Decline Is a ‘Solid’ Buying OpportunityDeutsche Bank Research analyst Steve Powers upgraded Kenvue to Buy from Hold over the weekend.
Read more »

Monk Prayogshala Research InstitutionMonk Prayogshala Research InstitutionMonk Prayogshala Research Institution is a not-for-profit academic research institution in Mumbai, India.
Read more »

4 Huge Analyst Calls: Block Slashed on 'Lack of Catalysts'; Chewy Bumped to Buy4 Huge Analyst Calls: Block Slashed on 'Lack of Catalysts'; Chewy Bumped to BuyStocks Analysis by Investing.com (Garrett Cook) covering: Block Inc, Chewy Inc, Cloudflare Inc, Surf Air Mobility Inc. Read Investing.com (Garrett Cook)'s latest article on Investing.com
Read more »

Cardano Heads into Depression, As New ADA Price Prediction From Top Analyst ShowsCardano Heads into Depression, As New ADA Price Prediction From Top Analyst ShowsNothing good for Cardano in next nine months as Benjamin Cowen unveils epic ADA price prediction
Read more »

Here are Monday's biggest analyst calls: Tesla, Apple, Nvidia, Amazon, Microsoft, Block, Netflix & moreHere are Monday's biggest analyst calls: Tesla, Apple, Nvidia, Amazon, Microsoft, Block, Netflix & moreHere are the biggest calls on Wall Street on Monday.
Read more »



Render Time: 2025-03-06 16:40:27